Payment overview · 2025
General Payments
$17.58
1 reported records · 1 companies
Healthcare provider profile · identity verified
Chacey Bryan, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · WILMINGTON, NC · NPI 1699228734
Verified facts
What the public records show
CMS Open Payments records show Chacey Bryan, M.D. received $17.58 in general payments during 2025 across 1 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $17.58 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.58 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $17.58 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 723 | 107 |
| Gabapentin | Gabapentin | 413 | 65 |
| Amlodipine Besylate | Amlodipine Besylate | 407 | 70 |
| Eliquis | Apixaban | 327 | 39 |
| Tamsulosin Hcl | Tamsulosin Hcl | 284 | 36 |
| Pantoprazole Sodium | Pantoprazole Sodium | 277 | 45 |
| Levothyroxine Sodium | Levothyroxine Sodium | 270 | 46 |
| Furosemide | Furosemide | 230 | 45 |
| Trazodone Hcl | Trazodone Hcl | 227 | 41 |
| Lisinopril | Lisinopril | 223 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 220 | 33 |
| Losartan Potassium | Losartan Potassium | 197 | 31 |
| Carvedilol | Carvedilol | 175 | 27 |
| Divalproex Sodium | Divalproex Sodium | 141 | 35 |
| Nifedipine Er | Nifedipine | 131 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 130 | 15 |
| Metformin Hcl | Metformin Hcl | 127 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 123 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 114 | 12 |
| Mirtazapine | Mirtazapine | 109 | 23 |
| Donepezil Hcl | Donepezil Hcl | 108 | 18 |
| Buspirone Hcl | Buspirone Hcl | 107 | 11 |
| Metoprolol Succinate | Metoprolol Succinate | 106 | 26 |
| Quetiapine Fumarate | Quetiapine Fumarate | 105 | 21 |
| Montelukast Sodium | Montelukast Sodium | 100 | 14 |
| Latanoprost | Latanoprost | 96 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 94 | 14 |
| Potassium Chloride | Potassium Chloride | 94 | 23 |
| Levetiracetam | Levetiracetam | 88 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 86 | 16 |
| Sertraline Hcl | Sertraline Hcl | 82 | 22 |
| Trulicity | Dulaglutide | 78 | suppressed |
| Xarelto | Rivaroxaban | 76 | suppressed |
| Lamotrigine | Lamotrigine | 75 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 74 | suppressed |
| Memantine Hcl | Memantine Hcl | 72 | 14 |
| Risperidone | Risperidone | 70 | suppressed |
| Jardiance | Empagliflozin | 69 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 67 | 14 |
| Olanzapine | Olanzapine | 67 | suppressed |
| Baclofen | Baclofen | 66 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 66 | 18 |
| Midodrine Hcl | Midodrine Hcl | 64 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 64 | suppressed |
| Omeprazole | Omeprazole | 63 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 62 | 14 |
| Ezetimibe | Ezetimibe | 61 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 57 | 16 |
| Sucralfate | Sucralfate | 56 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 54 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 54 | 17 |
| Meloxicam | Meloxicam | 54 | 12 |
| Simvastatin | Simvastatin | 54 | 11 |
| Finasteride | Finasteride | 52 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 50 | suppressed |
| Allopurinol | Allopurinol | 47 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 44 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 43 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 43 | suppressed |
| Myrbetriq | Mirabegron | 42 | suppressed |
| Nystatin | Nystatin | 39 | 15 |
| Albuterol Sulfate | Albuterol Sulfate | 38 | 25 |
| Brilinta | Ticagrelor | 38 | suppressed |
| Spironolactone | Spironolactone | 38 | 12 |
| Entresto | Sacubitril/Valsartan | 37 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 36 | 21 |
| Atenolol | Atenolol | 36 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 35 | 22 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 35 | 15 |
| Mirabegron Er | Mirabegron | 35 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 35 | suppressed |
| Azithromycin | Azithromycin | 34 | 19 |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Digoxin | Digoxin | 32 | suppressed |
| Prednisone | Prednisone | 32 | 13 |
| Warfarin Sodium | Warfarin Sodium | 32 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 31 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 30 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 29 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 28 | 17 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 15 |
| Torsemide | Torsemide | 28 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 27 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 27 | suppressed |
| Glimepiride | Glimepiride | 27 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 26 | suppressed |
| Klor-Con 10 | Potassium Chloride | 25 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 25 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Zonisamide | Zonisamide | 25 | suppressed |
| Levofloxacin | Levofloxacin | 24 | 13 |
| Tradjenta | Linagliptin | 24 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Acetylcysteine | Acetylcysteine | 22 | suppressed |
| Anastrozole | Anastrozole | 22 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 22 | suppressed |
| Budesonide | Budesonide | 21 | suppressed |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 21 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 21 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Amantadine | Amantadine Hcl | 19 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 19 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 19 | 16 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 19 | 13 |
| Lidocaine Hcl | Lidocaine Hcl | 19 | 14 |
| Lokelma | Sodium Zirconium Cyclosilicate | 19 | 12 |
| Epidiolex | Cannabidiol (Cbd) | 18 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 18 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Azathioprine | Azathioprine | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Clozapine | Clozapine | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Famotidine | Famotidine | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | 12 |
| Perphenazine | Perphenazine | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Cefdinir | Cefdinir | 14 | 11 |
| Cephalexin | Cephalexin | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 12 |
| Celecoxib | Celecoxib | 13 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 13 | suppressed |
| Ingrezza | Valbenazine Tosylate | 13 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 13 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Verapamil Sr | Verapamil Hcl | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 11 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Lorazepam | Lorazepam | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.58 · 1 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error